Member Sign In
Member Sign Out
Cancer & Disease Research
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Already have an account?
Sign in using your social networking account:
Sign in using your social networking
Forgot your password?
Bacteria vary between early- vs. late-onset colorectal cancer tumors: Study
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiomes of people with colorectal cancer and found that the makeup of bacteria, fungi, and viruses in their tumors varied significantly depending on whether they had early-onset (age 45 or younger) or late-onset (age 65 or older) disease.
Scientists seek HIV cure by transplanting stem cells to monkeys
Scientists are seeking a cure for HIV via stem cell transplants on monkeys. Their research, published Thursday in the journal
, describes the process by which two of four non-human primates were cured of HIV following stem cell transplantation.
Biomarkers in a study predict stem cell transplant risks
Risk biomarkers uncovered in a recent study may help medical staff predict which donor stem cell transplant patients are likely to develop a potentially deadly side effect called sinusoidal obstruction syndrome (SOS).
Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptoms
Fully vaccinated individuals had a lower risk of dying or developing some non-respiratory symptoms than people without protection against COVID-19 during the Delta and Omicron waves, a retrospective review of medical records has found.
FDA approves first topical gene therapy for treatment of wounds in patients with dystrophic epidermolysis bullosa
The U.S. Food and Drug Administration (FDA) said on Friday it has approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients six months of age and older with dystrophic epidermolysis bullosa (DEB) and with mutations in the collagen type VII alpha 1 chain (COL7A1) gene.
Revvity, AstraZeneca ink license agreement for next-gen base editing tech
Revvity this week announced a nonexclusive license agreement with AstraZeneca for the technology underlying a next-generation modular gene editing platform.
Alzheimer’s disease and modifiable risk factors: Genetic associations revealed
A genetic association study comparing participants with Alzheimer’s disease and control participants without Alzheimer’s disease found novel genetic associations between high high-density lipoprotein (HDL) cholesterol concentrations and high systolic blood pressure and a higher risk of Alzheimer’s disease.
Boundless Bio closes $100 million Series C financing to advance precision oncology therapies
Next-generation precision oncology company Boundless Bio on Tuesday announced the closing of its $100 million Series C financing, which will be used to advance the clinical development of its BBI-355 extrachromosomal DNA-directed oncology therapy.
Clinical trial begins for universal flu vaccine candidate
Researchers at NIH’s National Institute of Allergy and Infectious Diseases (NIAIDs) have developed an experimental universal influenza vaccine.
Biomarker predicts response to chemo-immunotherapy in lung cancer patients
Researchers have found a biomarker that provides an early indication of whether a patient is responding to chemo-immunotherapy.
International Paper Physics Conference 2023 (IPPC2023)
May 31 - June 2
Guangzhou, Guangdong China
More Conferences »»
Roche launches Institute of Human Biology for human model systems to advance research and drug development
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Theratechnologies data suggests tesamorelin may improve metabolic profiles in people with HIV
Quanterix expands laboratory-developed-test menu with launch of neurofilament light chain test
Grail launches methylation-based liquid biopsy solution for cancer research in a post-diagnosis setting
More articles »
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard